Peptide laws in China

The NMPA approves thymosin alpha-1 and several domestic peptide drugs. China is also the world's dominant manufacturer of research peptides for export, creating a stark gap between domestic regulation and export volume.

Customs and enforcement practice can differ sharply from the written rule. Penalties for importing unapproved injectables range from seizure to criminal prosecution depending on the jurisdiction. Confirm current rules with the named authority before ordering anything across a border.